FDA Approved: ORBACTIV — Supplemental Application (Melinta Therapeutics, LLC)

View source ↗

Summary

FDA approved a supplemental application for ORBACTIV (oritavancin) submitted by Melinta Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Orbactiv (oritavancin)

Snippet

SUPPL AP for ORBACTIV (ORITAVANCIN)